Strategy& adds Till Giese as partner to Pharma & Life Sciences team

10 July 2024 1 min. read
More news on

Strategy& has appointed Germany-based Till Giese as a partner in its Pharma & Life Sciences division.

Operating out of Hamburg, the 42-year old Till Giese brings over 15 years of experience in strategy development, strategy implementation, digitization, operational excellence, research & development, and industry 4.0 to Strategy&.

Giese has extensive experience advising clients in the pharmaceutical and life science sectors, as well as healthcare, and chemicals. He has advised a diverse range of clients both internationally and in Germany.

Strategy& adds Till Giese as partner to Pharma & Life Sciences team

His track record includes supporting the European growth strategy development and implementation for an Italian MedTech company, helping a French pharma company drive its industry 4.0 strategy, and advising a German hospital on a performance improvement program.

Giese joins Strategy& from Porsche Consulting, where he spent over ten years, growing the ranks to associate partner. Before that, he worked for 3con Management Consultants, and was a researcher and lecturer at the Technical University of Munich.

Commenting on the appointment, Thomas Solbach, Partner and Head of the Pharma & Life Sciences Practice, said: “The healthcare sector is in the midst of what is probably its greatest transformation. Digitization and medical development are progressing at an unprecedented speed. At the same time, the pressure to innovate and reduce costs is increasing, while patients are upping their expectations.”

“To successfully navigate this challenging business environment, the medical industry needs visionary and at the same time pragmatic strategies with which it can further develop – or even reinvent – its business models in a future-proof manner. With Till on board, we are expanding our consulting services to help our clients respond to these challenges.”